Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
  • Legit.Health Plus Version 1.1.0.1
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • Grants
    • Planning
    • Red.es RedIA Salud 2025
    • EPIC-X 2026
      • Instructions (CLAUDE.md)
      • Application
        • Section 1: Executive Summary
        • Section 2: Excellence and Innovation (40 Points)
        • Section 3: Impact and Market Potential (25 Points)
        • Section 4: Implementation and Capacity (35 Points)
        • Section 5: Business Coaching Plan (10 Points)
        • Section 6: Women Leadership (10 Points)
      • Resources
      • EPIC-X Grant Application - Data Request for Teams
      • EPIC-X 2026 Grant Application: Gap Analysis & Prioritization
      • EPIC-X 2026 Application - Quality Review Checklist
  • Pricing
  • Public tenders
  • Grants
  • EPIC-X 2026
  • Application

Application

📄️ Section 1: Executive Summary

Company Overview

📄️ Section 2: Excellence and Innovation (40 Points)

This section addresses the Excellence and Innovation evaluation criteria (40 points total):

📄️ Section 3: Impact and Market Potential (25 Points)

This section addresses the Impact and Market Potential evaluation criteria (25 points total):

📄️ Section 4: Implementation and Capacity (35 Points)

This section addresses the Implementation and Capacity evaluation criteria (35 points total):

📄️ Section 5: Business Coaching Plan (10 Points)

EPIC-X Requirement: Minimum EUR 20,000 (33.3% of EUR 60,000 grant) allocated for business coaching over 15-20 days

📄️ Section 6: Women Leadership (10 Points)

EPIC-X Core Mission: Accelerating women-led deep-tech startups to drive European innovation and gender equality in entrepreneurship

Previous
Instructions (CLAUDE.md)
Next
Section 1: Executive Summary
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)